Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
DURECT Corp. (DRRX)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on DRRX
Newest on DRRX
M. E. Garza
(1)
Mike Havrilla
(2)
Zacks.com
(1)
H.S. Ayoub
(1)
SA Editor Jonathan Liss
(1)
Most frequent on DRRX
Mike Havrilla
(
2
)
SA Editor Jonathan Liss
(
1
)
H.S. Ayoub
(
1
)
Zacks.com
(
1
)
M. E. Garza
(
1
)
Most followed on DRRX
Mike Havrilla
(
1130
)
Zacks.com
(
592
)
M. E. Garza
(
124
)
SA Editor Jonathan Liss
(
73
)
H.S. Ayoub
(
3
)
Most commented on DRRX
Mike Havrilla
(
7
)
M. E. Garza
(
1
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on DURECT Corp. (DRRX)
by
latest
|
most commented
FDA Calendar Updates: King Pharma, Pain Therapeutics
Jul 8
•
Mike Havrilla
•
CBST
,
ALTH
,
DRRX
•
6 Comments
|
Quick Read
Durect: Be Patient Investors, Better Times Are Ahead
Jun 17
•
Zacks.com
•
DRRX
•
Comment!
|
Quick Read
Biggest Health Care Winners Become Biggest Losers After Friday's Market Action
Jun 7
•
M. E. Garza
•
BDSI
,
AGEN
,
COV
•
1 Comment
|
Quick Read
FDA and Clinical Trial Updates: United Therapeutics Faces Delays
Mar 18
•
Mike Havrilla
•
CEPH
,
BAYRY.PK
,
DRRX
•
1 Comment
|
Quick Read
Durect Shares Up 20% On Painkiller Deal
Dec 1, 2006
•
SA Editor Jonathan Liss
•
DRRX
•
Comment!
|
Quick Read
Painkiller Deal Good News for Durect Corp.
Dec 1, 2006
•
H.S. Ayoub
•
DRRX
•
Comment!
|
Quick Read